Comparing Post-Op Narcotic Usage in Patients Receiving Periarticular Exparel vs. Standard Periarticular Joint Inj
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
This study seeks to determine whether a new sustained-release local anesthetic solution
(Exparel - Liposomal Bupivacaine) injected into the soft tissues around the joint after
surgery will decrease opioid consumption and adverse events in opioid-tolerant patients
presenting for total knee arthroplasty. The research hypothesis is that the Exparel (study)
group will use less opioid in the first 48 hours post-operatively than the control group.